Hybrid Molecules from Xanomeline and Tacrine: Enhanced Tacrine Actions on Cholinesterases and Muscarinic M1 Receptors

被引:48
|
作者
Fang, Lei [2 ,3 ]
Jumpertz, Sabine [1 ]
Zhang, Yihua [2 ]
Appenroth, Dorothea [4 ]
Fleck, Christian [4 ]
Mohr, Klaus [1 ]
Traenkle, Christian [1 ]
Decker, Michael [3 ]
机构
[1] Univ Bonn, Inst Pharmazeut, D-53121 Bonn, Germany
[2] China Pharmaceut Univ, Ctr Drug Discovery, Nanjing 210009, Peoples R China
[3] Univ Jena, Inst Pharm, Lehrstuhl Pharmazeut Med Chem, D-07743 Jena, Germany
[4] Univ Jena, Inst Pharmakol & Toxikol, D-07740 Jena, Germany
关键词
HIGHLY POTENT; ACETYLCHOLINE-RECEPTORS; ALLOSTERIC INTERACTIONS; ALZHEIMERS-DISEASE; BINDING; LIGANDS; AGONISTS; DESIGN; SITE; MODULATORS;
D O I
10.1021/jm901616h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A set of amide- and amine-linked hybrid molecules comprising moieties of the orthosteric M-1 muscarinic receptor agonist xanomeline and the cholinesterase inhibitor and allosteric receptor modulator tacrine were prepared with varying spacer length of 10-17 atoms. The hybrids inhibited acetylcholinesterase with similar or higher potency compared to tacrine. M, receptor binding affinity was similar or higher relative to xanomeline and far higher relative to tacrine. Affinities hardly changed when the receptors' orthosteric site was Occupied by all inverse agonist ligand. When Occupied by the orthosteric activator acetylcholine, affinity for the hybrids declined to unmeasureably low levels. Hybrids did not activate M-1 receptors. In vivo studies assaying cognition impairment in rats induced by scopolamine revealed pronounced enhancement of scopolamine action. Taken together, instead of dualsteric (simultaneous allosteric/orthosteric) binding, the hybrids seem to prefer purely allosteric binding at the inactive M-1 receptor.
引用
收藏
页码:2094 / 2103
页数:10
相关论文
共 50 条
  • [1] Tacrine-xanomeline and tacrine-iperoxo hybrid ligands: Synthesis and biological evaluation at acetylcholinesterase and M1 muscarinic acetylcholine receptors
    Maspero, Marco
    Volpato, Daniela
    Cirillo, Davide
    Chen, Natalia Yuan
    Messerer, Regina
    Sotriffer, Christoph
    De Amici, Marco
    Holzgrabe, Ulrike
    Dallanoce, Clelia
    [J]. BIOORGANIC CHEMISTRY, 2020, 96
  • [2] Allosteric muscarinic M1 receptor action of hybrids related to the M1 agonist xanomeline and to tacrine
    Jumpertz, S.
    Fang, L.
    Decker, M.
    Zhang, Y.
    Mohr, K.
    Traenkle, C.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 15 - 15
  • [3] Allosteric actions of the atypical allosteric agent tacrine and of a novel "tacrine dimer" in muscarinic M2 receptors
    Dittmann, A
    Weyand, O
    Holzgrabe, U
    Mohr, K
    Tränkle, C
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R26 - R26
  • [4] First Gallamine-Tacrine hybrid:: Design and characterization at cholinesterases and the M2 muscarinic receptor
    Elsinghorst, Paul W.
    Cieslik, Julia S.
    Mohr, Klaus
    Traenkle, Christian
    Guetschow, Michael
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (23) : 5685 - 5695
  • [5] Pharmacological determination of the interaction of xanomeline with M1 muscarinic acetylcholine receptors.
    Parsons, AM
    Christopoulos, A
    El-Fakahany, EE
    [J]. LIFE SCIENCES, 1999, 64 (6-7) : 578 - 578
  • [6] Pharmacological analysis of the mode of interaction of xanomeline at M1 muscarinic acetylcholine receptors
    Christopoulos, A
    Parsons, AM
    El-Fakahany, EE
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R85 - R85
  • [7] Evidence for an uncommon allosteric binding mode of tacrine at muscarinic M2-receptors
    Schulz, U
    Tränkle, C
    Mohr, K
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R22 - R22
  • [8] Persistent receptor activation by the M1 muscarinic agonist, xanomeline
    El-Fakahany, EE
    Christopoulos, A
    Pierce, TL
    Sorman, JL
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 : 32S - 32S
  • [9] Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2
    Messerer, Regina
    Dallanoce, Clelia
    Matera, Carlo
    Wehle, Sarah
    Flammini, Lisa
    Chirinda, Brian
    Bock, Andreas
    Irmen, Matthias
    Traenkle, Christian
    Barocelli, Elisabetta
    Decker, Michael
    Sotriffer, Christoph
    De Amici, Marco
    Holzgrabe, Ulrike
    [J]. MEDCHEMCOMM, 2017, 8 (06) : 1346 - 1359
  • [10] Mutant M1 muscarinic receptors with enhanced agonist activity
    Huang, XP
    Williams, FE
    Peseckis, SM
    Messer, WS
    [J]. LIFE SCIENCES, 1999, 64 (6-7) : 563 - 563